
Carna Biosciences, Inc. (Securities Code: 4572) reported its Q2 2026 financial results,

Carna Biosciences (4572) has released its financial results, reporting net sales of 410 million yen, representing a year-on-year increase of +59.8%. However, the company posted an operating loss of 95